Sergey Vasnetsov - 15 Nov 2022 Form 4 Insider Report for ASP Isotopes Inc. (ASPI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Nov 2022, 11:47:45 UTC
Prior SEC filing
14 Nov 2022
Next SEC filing
22 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sergey Vasnetsov

Key filing fact

Sergey Vasnetsov filed Form 4 for ASP Isotopes Inc. (ASPI) on 16 Nov 2022.

Key facts

  • This page summarizes Sergey Vasnetsov's Form 4 filing for ASP Isotopes Inc. (ASPI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Nov 2022, 11:47.

Change

  • Previous filing in this sequence was filed on 14 Nov 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASPI transaction

Common Stock

Award

Transaction value
$0
Shares
+600,000
Change %
+27%
Price
$0.000000
Shares after
2,800,000
Date
15 Nov 2022
Ownership
See Foot note
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This special one-time equity award of 600,000 restricted shares were contingent upon the completion of our IPO. Mr. Vasnetsov will receive 150,000 restricted shares of our common stock on November 15, 2023, 150,000 restricted shares of our common stock on November 15, 2024, 150,000 restricted shares of our common stock on November 15, 2025, and 150,000 shares of our restricted common stock on November 15, 2026.

Footnote F2

Mr. Vasnetsov beneficially owns 1,000,000 shares indirectly through Elista LLC and beneficially owns 1,800,000 shares indirectly through ChemBridges LLC.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .